Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition

por Sison, Edward Allan R., Magoon, Daniel, Li, Li, Annesley, Colleen E., Rau, Rachel E., Small, Donald, Brown, Patrick
Publicado 2014

POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL

por Sison, Edward Allan R., Magoon, Daniel, Li, Li, Annesley, Colleen E., Romagnoli, Barbara, Douglas, Garry J., Tuffin, Gerald, Zimmermann, Johann, Brown, Patrick
Publicado 2015

Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice

por Annesley, Colleen E., Rabik, Cara, Duffield, Amy S., Rau, Rachel E., Magoon, Daniel, Li, Li, Huff, Vicki, Small, Donald, Loeb, David M., Brown, Patrick
Publicado 2018